Global Neurologic Disorder Treatment Drug Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neurologic Disorder Treatment Drug Market Size 2017-2028

2.1.2 Neurologic Disorder Treatment Drug Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Neurologic Disorder Treatment Drug Segment by Type

2.2.1 Anticholinergic

2.2.2 Antiepileptic

2.2.3 Antipsychotic

2.2.4 Hypnotic and Sedative

2.2.5 Analgesics

2.2.6 Antihypertensive

2.2.7 Anticoagulants

2.2.8 Others

2.3 Neurologic Disorder Treatment Drug Market Size by Type

2.3.1 Neurologic Disorder Treatment Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Neurologic Disorder Treatment Drug Market Size Market Share by Type (2017-2022)

2.4 Neurologic Disorder Treatment Drug Segment by Application

2.4.1 Epilepsy

2.4.2 Alzheimer’s Disease

2.4.3 Parkinson's Disease

2.4.4 Multiple Sclerosis

2.4.5 Cerebrovascular Disease

2.4.6 Others

2.5 Neurologic Disorder Treatment Drug Market Size by Application

2.5.1 Neurologic Disorder Treatment Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Neurologic Disorder Treatment Drug Market Size Market Share by Application (2017-2022)

3 Neurologic Disorder Treatment Drug Market Size by Player

3.1 Neurologic Disorder Treatment Drug Market Size Market Share by Players

3.1.1 Global Neurologic Disorder Treatment Drug Revenue by Players (2020-2022)

3.1.2 Global Neurologic Disorder Treatment Drug Revenue Market Share by Players (2020-2022)

3.2 Global Neurologic Disorder Treatment Drug Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Neurologic Disorder Treatment Drug by Regions

4.1 Neurologic Disorder Treatment Drug Market Size by Regions (2017-2022)

4.2 Americas Neurologic Disorder Treatment Drug Market Size Growth (2017-2022)

4.3 APAC Neurologic Disorder Treatment Drug Market Size Growth (2017-2022)

4.4 Europe Neurologic Disorder Treatment Drug Market Size Growth (2017-2022)

4.5 Middle East & Africa Neurologic Disorder Treatment Drug Market Size Growth (2017-2022)

5 Americas

5.1 Americas Neurologic Disorder Treatment Drug Market Size by Country (2017-2022)

5.2 Americas Neurologic Disorder Treatment Drug Market Size by Type (2017-2022)

5.3 Americas Neurologic Disorder Treatment Drug Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neurologic Disorder Treatment Drug Market Size by Region (2017-2022)

6.2 APAC Neurologic Disorder Treatment Drug Market Size by Type (2017-2022)

6.3 APAC Neurologic Disorder Treatment Drug Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Neurologic Disorder Treatment Drug by Country (2017-2022)

7.2 Europe Neurologic Disorder Treatment Drug Market Size by Type (2017-2022)

7.3 Europe Neurologic Disorder Treatment Drug Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neurologic Disorder Treatment Drug by Region (2017-2022)

8.2 Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Type (2017-2022)

8.3 Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Neurologic Disorder Treatment Drug Market Forecast

10.1 Global Neurologic Disorder Treatment Drug Forecast by Regions (2023-2028)

10.1.1 Global Neurologic Disorder Treatment Drug Forecast by Regions (2023-2028)

10.1.2 Americas Neurologic Disorder Treatment Drug Forecast

10.1.3 APAC Neurologic Disorder Treatment Drug Forecast

10.1.4 Europe Neurologic Disorder Treatment Drug Forecast

10.1.5 Middle East & Africa Neurologic Disorder Treatment Drug Forecast

10.2 Americas Neurologic Disorder Treatment Drug Forecast by Country (2023-2028)

10.2.1 United States Neurologic Disorder Treatment Drug Market Forecast

10.2.2 Canada Neurologic Disorder Treatment Drug Market Forecast

10.2.3 Mexico Neurologic Disorder Treatment Drug Market Forecast

10.2.4 Brazil Neurologic Disorder Treatment Drug Market Forecast

10.3 APAC Neurologic Disorder Treatment Drug Forecast by Region (2023-2028)

10.3.1 China Neurologic Disorder Treatment Drug Market Forecast

10.3.2 Japan Neurologic Disorder Treatment Drug Market Forecast

10.3.3 Korea Neurologic Disorder Treatment Drug Market Forecast

10.3.4 Southeast Asia Neurologic Disorder Treatment Drug Market Forecast

10.3.5 India Neurologic Disorder Treatment Drug Market Forecast

10.3.6 Australia Neurologic Disorder Treatment Drug Market Forecast

10.4 Europe Neurologic Disorder Treatment Drug Forecast by Country (2023-2028)

10.4.1 Germany Neurologic Disorder Treatment Drug Market Forecast

10.4.2 France Neurologic Disorder Treatment Drug Market Forecast

10.4.3 UK Neurologic Disorder Treatment Drug Market Forecast

10.4.4 Italy Neurologic Disorder Treatment Drug Market Forecast

10.4.5 Russia Neurologic Disorder Treatment Drug Market Forecast

10.5 Middle East & Africa Neurologic Disorder Treatment Drug Forecast by Region (2023-2028)

10.5.1 Egypt Neurologic Disorder Treatment Drug Market Forecast

10.5.2 South Africa Neurologic Disorder Treatment Drug Market Forecast

10.5.3 Israel Neurologic Disorder Treatment Drug Market Forecast

10.5.4 Turkey Neurologic Disorder Treatment Drug Market Forecast

10.5.5 GCC Countries Neurologic Disorder Treatment Drug Market Forecast

10.6 Global Neurologic Disorder Treatment Drug Forecast by Type (2023-2028)

10.7 Global Neurologic Disorder Treatment Drug Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 AbbVie

11.1.1 AbbVie Company Information

11.1.2 AbbVie Neurologic Disorder Treatment Drug Product Offered

11.1.3 AbbVie Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 AbbVie Main Business Overview

11.1.5 AbbVie Latest Developments

11.2 Acadia Pharmaceuticals

11.2.1 Acadia Pharmaceuticals Company Information

11.2.2 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Offered

11.2.3 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Acadia Pharmaceuticals Main Business Overview

11.2.5 Acadia Pharmaceuticals Latest Developments

11.3 Acorda Therapeutics Biotechnology

11.3.1 Acorda Therapeutics Biotechnology Company Information

11.3.2 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Offered

11.3.3 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Acorda Therapeutics Biotechnology Main Business Overview

11.3.5 Acorda Therapeutics Biotechnology Latest Developments

11.4 Bayer

11.4.1 Bayer Company Information

11.4.2 Bayer Neurologic Disorder Treatment Drug Product Offered

11.4.3 Bayer Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Bayer Main Business Overview

11.4.5 Bayer Latest Developments

11.5 Biogen

11.5.1 Biogen Company Information

11.5.2 Biogen Neurologic Disorder Treatment Drug Product Offered

11.5.3 Biogen Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Biogen Main Business Overview

11.5.5 Biogen Latest Developments

11.6 CSK

11.6.1 CSK Company Information

11.6.2 CSK Neurologic Disorder Treatment Drug Product Offered

11.6.3 CSK Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 CSK Main Business Overview

11.6.5 CSK Latest Developments

11.7 Eisai

11.7.1 Eisai Company Information

11.7.2 Eisai Neurologic Disorder Treatment Drug Product Offered

11.7.3 Eisai Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Eisai Main Business Overview

11.7.5 Eisai Latest Developments

11.8 F. Hoffmann La Roche

11.8.1 F. Hoffmann La Roche Company Information

11.8.2 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Offered

11.8.3 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 F. Hoffmann La Roche Main Business Overview

11.8.5 F. Hoffmann La Roche Latest Developments

11.9 H Lundbeck

11.9.1 H Lundbeck Company Information

11.9.2 H Lundbeck Neurologic Disorder Treatment Drug Product Offered

11.9.3 H Lundbeck Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 H Lundbeck Main Business Overview

11.9.5 H Lundbeck Latest Developments

11.10 Johnson and Johnson

11.10.1 Johnson and Johnson Company Information

11.10.2 Johnson and Johnson Neurologic Disorder Treatment Drug Product Offered

11.10.3 Johnson and Johnson Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Johnson and Johnson Main Business Overview

11.10.5 Johnson and Johnson Latest Developments

11.11 Merck

11.11.1 Merck Company Information

11.11.2 Merck Neurologic Disorder Treatment Drug Product Offered

11.11.3 Merck Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Merck Main Business Overview

11.11.5 Merck Latest Developments

11.12 Novartis

11.12.1 Novartis Company Information

11.12.2 Novartis Neurologic Disorder Treatment Drug Product Offered

11.12.3 Novartis Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Novartis Main Business Overview

11.12.5 Novartis Latest Developments

11.13 Otsuka Pharmaceutical

11.13.1 Otsuka Pharmaceutical Company Information

11.13.2 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Offered

11.13.3 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Otsuka Pharmaceutical Main Business Overview

11.13.5 Otsuka Pharmaceutical Latest Developments

11.14 Pfizer

11.14.1 Pfizer Company Information

11.14.2 Pfizer Neurologic Disorder Treatment Drug Product Offered

11.14.3 Pfizer Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Pfizer Main Business Overview

11.14.5 Pfizer Latest Developments

11.15 Sanofi

11.15.1 Sanofi Company Information

11.15.2 Sanofi Neurologic Disorder Treatment Drug Product Offered

11.15.3 Sanofi Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Sanofi Main Business Overview

11.15.5 Sanofi Latest Developments

11.16 Takeda Pharmaceutical

11.16.1 Takeda Pharmaceutical Company Information

11.16.2 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Offered

11.16.3 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Takeda Pharmaceutical Main Business Overview

11.16.5 Takeda Pharmaceutical Latest Developments

11.17 Teva Pharmaceutical Industries

11.17.1 Teva Pharmaceutical Industries Company Information

11.17.2 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Offered

11.17.3 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Teva Pharmaceutical Industries Main Business Overview

11.17.5 Teva Pharmaceutical Industries Latest Developments

11.18 UCB

11.18.1 UCB Company Information

11.18.2 UCB Neurologic Disorder Treatment Drug Product Offered

11.18.3 UCB Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 UCB Main Business Overview

11.18.5 UCB Latest Developments

11.19 USWM

11.19.1 USWM Company Information

11.19.2 USWM Neurologic Disorder Treatment Drug Product Offered

11.19.3 USWM Neurologic Disorder Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 USWM Main Business Overview

11.19.5 USWM Latest Developments

12 Research Findings and Conclusion

Table 1. Neurologic Disorder Treatment Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Anticholinergic

Table 3. Major Players of Antiepileptic

Table 4. Major Players of Antipsychotic

Table 5. Major Players of Hypnotic and Sedative

Table 6. Major Players of Analgesics

Table 7. Major Players of Antihypertensive

Table 8. Major Players of Anticoagulants

Table 9. Major Players of Others

Table 10. Neurologic Disorder Treatment Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Neurologic Disorder Treatment Drug Market Size by Type (2017-2022) & ($ Millions)

Table 12. Global Neurologic Disorder Treatment Drug Market Size Market Share by Type (2017-2022)

Table 13. Neurologic Disorder Treatment Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 14. Global Neurologic Disorder Treatment Drug Market Size by Application (2017-2022) & ($ Millions)

Table 15. Global Neurologic Disorder Treatment Drug Market Size Market Share by Application (2017-2022)

Table 16. Global Neurologic Disorder Treatment Drug Revenue by Players (2020-2022) & ($ Millions)

Table 17. Global Neurologic Disorder Treatment Drug Revenue Market Share by Player (2020-2022)

Table 18. Neurologic Disorder Treatment Drug Key Players Head office and Products Offered

Table 19. Neurologic Disorder Treatment Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 20. New Products and Potential Entrants

Table 21. Mergers & Acquisitions, Expansion

Table 22. Global Neurologic Disorder Treatment Drug Market Size by Regions 2017-2022 & ($ Millions)

Table 23. Global Neurologic Disorder Treatment Drug Market Size Market Share by Regions (2017-2022)

Table 24. Americas Neurologic Disorder Treatment Drug Market Size by Country (2017-2022) & ($ Millions)

Table 25. Americas Neurologic Disorder Treatment Drug Market Size Market Share by Country (2017-2022)

Table 26. Americas Neurologic Disorder Treatment Drug Market Size by Type (2017-2022) & ($ Millions)

Table 27. Americas Neurologic Disorder Treatment Drug Market Size Market Share by Type (2017-2022)

Table 28. Americas Neurologic Disorder Treatment Drug Market Size by Application (2017-2022) & ($ Millions)

Table 29. Americas Neurologic Disorder Treatment Drug Market Size Market Share by Application (2017-2022)

Table 30. APAC Neurologic Disorder Treatment Drug Market Size by Region (2017-2022) & ($ Millions)

Table 31. APAC Neurologic Disorder Treatment Drug Market Size Market Share by Region (2017-2022)

Table 32. APAC Neurologic Disorder Treatment Drug Market Size by Type (2017-2022) & ($ Millions)

Table 33. APAC Neurologic Disorder Treatment Drug Market Size Market Share by Type (2017-2022)

Table 34. APAC Neurologic Disorder Treatment Drug Market Size by Application (2017-2022) & ($ Millions)

Table 35. APAC Neurologic Disorder Treatment Drug Market Size Market Share by Application (2017-2022)

Table 36. Europe Neurologic Disorder Treatment Drug Market Size by Country (2017-2022) & ($ Millions)

Table 37. Europe Neurologic Disorder Treatment Drug Market Size Market Share by Country (2017-2022)

Table 38. Europe Neurologic Disorder Treatment Drug Market Size by Type (2017-2022) & ($ Millions)

Table 39. Europe Neurologic Disorder Treatment Drug Market Size Market Share by Type (2017-2022)

Table 40. Europe Neurologic Disorder Treatment Drug Market Size by Application (2017-2022) & ($ Millions)

Table 41. Europe Neurologic Disorder Treatment Drug Market Size Market Share by Application (2017-2022)

Table 42. Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Region (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Market Share by Region (2017-2022)

Table 44. Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Type (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Market Share by Type (2017-2022)

Table 46. Middle East & Africa Neurologic Disorder Treatment Drug Market Size by Application (2017-2022) & ($ Millions)

Table 47. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Market Share by Application (2017-2022)

Table 48. Key Market Drivers & Growth Opportunities of Neurologic Disorder Treatment Drug

Table 49. Key Market Challenges & Risks of Neurologic Disorder Treatment Drug

Table 50. Key Industry Trends of Neurologic Disorder Treatment Drug

Table 51. Global Neurologic Disorder Treatment Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 52. Global Neurologic Disorder Treatment Drug Market Size Market Share Forecast by Regions (2023-2028)

Table 53. Global Neurologic Disorder Treatment Drug Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 54. Global Neurologic Disorder Treatment Drug Market Size Market Share Forecast by Type (2023-2028)

Table 55. Global Neurologic Disorder Treatment Drug Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 56. Global Neurologic Disorder Treatment Drug Market Size Market Share Forecast by Application (2023-2028)

Table 57. AbbVie Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 58. AbbVie Neurologic Disorder Treatment Drug Product Offered

Table 59. AbbVie Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. AbbVie Main Business

Table 61. AbbVie Latest Developments

Table 62. Acadia Pharmaceuticals Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 63. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Offered

Table 64. Acadia Pharmaceuticals Main Business

Table 65. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Acadia Pharmaceuticals Latest Developments

Table 67. Acorda Therapeutics Biotechnology Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 68. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Offered

Table 69. Acorda Therapeutics Biotechnology Main Business

Table 70. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Acorda Therapeutics Biotechnology Latest Developments

Table 72. Bayer Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 73. Bayer Neurologic Disorder Treatment Drug Product Offered

Table 74. Bayer Main Business

Table 75. Bayer Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Bayer Latest Developments

Table 77. Biogen Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 78. Biogen Neurologic Disorder Treatment Drug Product Offered

Table 79. Biogen Main Business

Table 80. Biogen Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Biogen Latest Developments

Table 82. CSK Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 83. CSK Neurologic Disorder Treatment Drug Product Offered

Table 84. CSK Main Business

Table 85. CSK Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. CSK Latest Developments

Table 87. Eisai Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 88. Eisai Neurologic Disorder Treatment Drug Product Offered

Table 89. Eisai Main Business

Table 90. Eisai Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Eisai Latest Developments

Table 92. F. Hoffmann La Roche Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 93. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Offered

Table 94. F. Hoffmann La Roche Main Business

Table 95. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. F. Hoffmann La Roche Latest Developments

Table 97. H Lundbeck Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 98. H Lundbeck Neurologic Disorder Treatment Drug Product Offered

Table 99. H Lundbeck Main Business

Table 100. H Lundbeck Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. H Lundbeck Latest Developments

Table 102. Johnson and Johnson Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 103. Johnson and Johnson Neurologic Disorder Treatment Drug Product Offered

Table 104. Johnson and Johnson Main Business

Table 105. Johnson and Johnson Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Johnson and Johnson Latest Developments

Table 107. Merck Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 108. Merck Neurologic Disorder Treatment Drug Product Offered

Table 109. Merck Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Merck Main Business

Table 111. Merck Latest Developments

Table 112. Novartis Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 113. Novartis Neurologic Disorder Treatment Drug Product Offered

Table 114. Novartis Main Business

Table 115. Novartis Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Novartis Latest Developments

Table 117. Otsuka Pharmaceutical Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 118. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Offered

Table 119. Otsuka Pharmaceutical Main Business

Table 120. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. Otsuka Pharmaceutical Latest Developments

Table 122. Pfizer Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 123. Pfizer Neurologic Disorder Treatment Drug Product Offered

Table 124. Pfizer Main Business

Table 125. Pfizer Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 126. Pfizer Latest Developments

Table 127. Sanofi Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 128. Sanofi Neurologic Disorder Treatment Drug Product Offered

Table 129. Sanofi Main Business

Table 130. Sanofi Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 131. Sanofi Latest Developments

Table 132. Takeda Pharmaceutical Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 133. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Offered

Table 134. Takeda Pharmaceutical Main Business

Table 135. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 136. Takeda Pharmaceutical Latest Developments

Table 137. Teva Pharmaceutical Industries Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 138. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Offered

Table 139. Teva Pharmaceutical Industries Main Business

Table 140. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 141. Teva Pharmaceutical Industries Latest Developments

Table 142. UCB Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 143. UCB Neurologic Disorder Treatment Drug Product Offered

Table 144. UCB Main Business

Table 145. UCB Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 146. UCB Latest Developments

Table 147. USWM Details, Company Type, Neurologic Disorder Treatment Drug Area Served and Its Competitors

Table 148. USWM Neurologic Disorder Treatment Drug Product Offered

Table 149. USWM Main Business

Table 150. USWM Neurologic Disorder Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 151. USWM Latest Developments

List of Figures

Figure 1. Neurologic Disorder Treatment Drug Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Neurologic Disorder Treatment Drug Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Neurologic Disorder Treatment Drug Market Size Market Share by Type in 2021

Figure 7. Neurologic Disorder Treatment Drug in Epilepsy

Figure 8. Global Neurologic Disorder Treatment Drug Market: Epilepsy (2017-2022) & ($ Millions)

Figure 9. Neurologic Disorder Treatment Drug in Alzheimer’s Disease

Figure 10. Global Neurologic Disorder Treatment Drug Market: Alzheimer’s Disease (2017-2022) & ($ Millions)

Figure 11. Neurologic Disorder Treatment Drug in Parkinson's Disease

Figure 12. Global Neurologic Disorder Treatment Drug Market: Parkinson's Disease (2017-2022) & ($ Millions)

Figure 13. Neurologic Disorder Treatment Drug in Multiple Sclerosis

Figure 14. Global Neurologic Disorder Treatment Drug Market: Multiple Sclerosis (2017-2022) & ($ Millions)

Figure 15. Neurologic Disorder Treatment Drug in Cerebrovascular Disease

Figure 16. Global Neurologic Disorder Treatment Drug Market: Cerebrovascular Disease (2017-2022) & ($ Millions)

Figure 17. Neurologic Disorder Treatment Drug in Others

Figure 18. Global Neurologic Disorder Treatment Drug Market: Others (2017-2022) & ($ Millions)

Figure 19. Global Neurologic Disorder Treatment Drug Market Size Market Share by Application in 2021

Figure 20. Global Neurologic Disorder Treatment Drug Revenue Market Share by Player in 2021

Figure 21. Global Neurologic Disorder Treatment Drug Market Size Market Share by Regions (2017-2022)

Figure 22. Americas Neurologic Disorder Treatment Drug Market Size 2017-2022 ($ Millions)

Figure 23. APAC Neurologic Disorder Treatment Drug Market Size 2017-2022 ($ Millions)

Figure 24. Europe Neurologic Disorder Treatment Drug Market Size 2017-2022 ($ Millions)

Figure 25. Middle East & Africa Neurologic Disorder Treatment Drug Market Size 2017-2022 ($ Millions)

Figure 26. Americas Neurologic Disorder Treatment Drug Value Market Share by Country in 2021

Figure 27. Americas Neurologic Disorder Treatment Drug Consumption Market Share by Type in 2021

Figure 28. Americas Neurologic Disorder Treatment Drug Market Size Market Share by Application in 2021

Figure 29. United States Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 30. Canada Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 31. Mexico Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 32. Brazil Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 33. APAC Neurologic Disorder Treatment Drug Market Size Market Share by Region in 2021

Figure 34. APAC Neurologic Disorder Treatment Drug Market Size Market Share by Application in 2021

Figure 35. China Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 36. Japan Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 37. Korea Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 38. Southeast Asia Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 39. India Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 40. Australia Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 41. Europe Neurologic Disorder Treatment Drug Market Size Market Share by Country in 2021

Figure 42. Europe Neurologic Disorder Treatment Drug Market Size Market Share by Type in 2021

Figure 43. Europe Neurologic Disorder Treatment Drug Market Size Market Share by Application in 2021

Figure 44. Germany Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 45. France Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 46. UK Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 47. Italy Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 48. Russia Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 49. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Market Share by Region in 2021

Figure 50. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Market Share by Type in 2021

Figure 51. Middle East & Africa Neurologic Disorder Treatment Drug Market Size Market Share by Application in 2021

Figure 52. Egypt Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 53. South Africa Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 54. Israel Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 55. Turkey Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 56. GCC Country Neurologic Disorder Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 57. Americas Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 58. APAC Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 59. Europe Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 60. Middle East & Africa Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 61. United States Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 62. Canada Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 63. Mexico Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 64. Brazil Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 65. China Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 66. Japan Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 67. Korea Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 68. Southeast Asia Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 69. India Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 70. Australia Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 71. Germany Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 72. France Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 73. UK Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 74. Italy Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 75. Russia Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 76. Spain Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 77. Egypt Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 78. South Africa Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 79. Israel Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 80. Turkey Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 81. GCC Countries Neurologic Disorder Treatment Drug Market Size 2023-2028 ($ Millions)